DE68925975T2 - Zusammensetzung zur Verhinderung der übertragung von AIDS. - Google Patents

Zusammensetzung zur Verhinderung der übertragung von AIDS.

Info

Publication number
DE68925975T2
DE68925975T2 DE68925975T DE68925975T DE68925975T2 DE 68925975 T2 DE68925975 T2 DE 68925975T2 DE 68925975 T DE68925975 T DE 68925975T DE 68925975 T DE68925975 T DE 68925975T DE 68925975 T2 DE68925975 T2 DE 68925975T2
Authority
DE
Germany
Prior art keywords
aids
preventing
composition
transmission
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68925975T
Other languages
English (en)
Other versions
DE68925975D1 (de
Inventor
Shanta Modak
Charles Fox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University of New York
Original Assignee
Columbia University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University of New York filed Critical Columbia University of New York
Application granted granted Critical
Publication of DE68925975D1 publication Critical patent/DE68925975D1/de
Publication of DE68925975T2 publication Critical patent/DE68925975T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
    • A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
    • A01N47/44—Guanidine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE68925975T 1988-10-18 1989-10-17 Zusammensetzung zur Verhinderung der übertragung von AIDS. Expired - Fee Related DE68925975T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/262,165 US4952411A (en) 1987-02-25 1988-10-18 Method of inhibiting the transmission of AIDS virus
PCT/US1989/004642 WO1990004390A1 (en) 1988-10-18 1989-10-17 Composition for inhibiting transmission of aids

Publications (2)

Publication Number Publication Date
DE68925975D1 DE68925975D1 (de) 1996-04-18
DE68925975T2 true DE68925975T2 (de) 1996-07-25

Family

ID=22996431

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925975T Expired - Fee Related DE68925975T2 (de) 1988-10-18 1989-10-17 Zusammensetzung zur Verhinderung der übertragung von AIDS.

Country Status (6)

Country Link
US (1) US4952411A (de)
EP (2) EP0439513B1 (de)
JP (1) JP2799210B2 (de)
AU (1) AU622945B2 (de)
DE (1) DE68925975T2 (de)
WO (1) WO1990004390A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334588A (en) * 1987-02-25 1994-08-02 The Trustees Of Columbia University In The City Of New York Composition for inhibiting transmission of hepatitis B virus
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
IT1239030B (it) * 1989-11-10 1993-09-20 Antonio Magni Preservativo.
US5336499A (en) * 1992-01-10 1994-08-09 Antelman Technologies, Ltd. Molecular crystal device for pharmaceuticals
CA2131615A1 (en) * 1992-03-18 1993-09-30 Shanta Modak Antiviral contraceptive devices, particularly condoms
US5849311A (en) 1996-10-28 1998-12-15 Biopolymerix, Inc. Contact-killing non-leaching antimicrobial materials
US7288264B1 (en) 1993-12-20 2007-10-30 Surfacine Development Company, L.L.C. Contact-killing antimicrobial devices
US5817325A (en) * 1996-10-28 1998-10-06 Biopolymerix, Inc. Contact-killing antimicrobial devices
DE69420862T2 (de) * 1993-12-20 2000-05-18 Biopolymerix Inc Flüssigkeitsdispensor zur abgabe von steriler flüssigkeit
US5676977A (en) * 1994-09-22 1997-10-14 Antelman Technologies Ltd. Method of curing AIDS with tetrasilver tetroxide molecular crystal devices
CA2225808C (en) * 1995-06-30 2002-12-17 Christopher C. Capelli Silver-based pharmaceutical compositions
GB9526395D0 (en) * 1995-12-22 1996-02-21 Procter & Gamble Cleansing compositions
JP2001508041A (ja) * 1996-10-28 2001-06-19 サーフィシニ デベロップメント カンパニー，エル エル シー 接触殺傷性・非侵出性抗菌材料
US6180584B1 (en) 1998-02-12 2001-01-30 Surfacine Development Company, Llc Disinfectant composition providing sustained residual biocidal action
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
US7179849B2 (en) 1999-12-15 2007-02-20 C. R. Bard, Inc. Antimicrobial compositions containing colloids of oligodynamic metals
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US6645531B1 (en) 2000-01-06 2003-11-11 Marantech Holding Llc Multivalent electron active compositions and methods of making and using same
US6669966B1 (en) 2000-01-06 2003-12-30 Marantech Holding Llc Compositions for facilitating skin growth and methods and articles using same
US20060105057A1 (en) * 2000-01-06 2006-05-18 Marantech Holding, Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US20040022868A1 (en) * 2000-01-06 2004-02-05 Marantech Holding Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US6485755B1 (en) 2000-01-06 2002-11-26 Marantech Holding Methods of using electron active compounds for managing cancer
US7137968B1 (en) 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials
US20030180379A1 (en) * 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
CA2417279C (en) 2000-07-27 2007-04-03 Nucryst Pharmaceuticals Corp. Treatment of hyperproliferative skin disorders and diseases
US20030206966A1 (en) * 2000-07-27 2003-11-06 Burrell Robert E. Methods of inducing apoptosis and modulating metalloproteinases
US7255881B2 (en) * 2000-07-27 2007-08-14 Nucryst Pharmaceuticals Corp. Metal-containing materials
US7008647B2 (en) 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US20030185901A1 (en) 2000-07-27 2003-10-02 Burrell Robert E. Methods of treating conditions with a metal-containing material
US7427416B2 (en) * 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials
DE60210441T2 (de) * 2001-04-23 2006-11-16 Nucryst Pharmaceuticals Corp., Fort Saskatchewan Arzneimittel oder pflaster enthaltend ein metall wie silber, gold, platin oder palladium als antimikrobiellen wirkstoff und dessen verwendung in der behandlung von hautentzündungen
US6593455B2 (en) 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
WO2003024995A1 (en) 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
CN1612804A (zh) 2001-12-03 2005-05-04 C·R·巴德公司 抗微生物医用器材、抗微生物聚合物涂层及其制备方法
US7201925B2 (en) * 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
AU2003286575A1 (en) * 2002-10-22 2004-05-13 Nucryst Pharmaceuticals Corp. Prophylactic treatment methods
WO2004069812A1 (en) * 2003-02-07 2004-08-19 Janssen Pharmaceutica N.V. Pyrimidine derivatives for the prevention of hiv infection
WO2006074117A2 (en) * 2005-01-05 2006-07-13 Robert Holladay Silver/water, silver gels and silver-based compositions; and methods for making and using the same
US7772284B2 (en) * 2003-08-27 2010-08-10 Labib Mohamed E Method for the treatment or prevention of virus infection using polybiguanide-based compounds
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060115495A1 (en) * 2004-11-12 2006-06-01 Board Of Regents, The University Of Texas System Protein-noble metal nanoparticles
WO2006056055A2 (en) * 2004-11-23 2006-06-01 Inernational Bio-Therapeutic Research Inc. Method of delivery of therapeutic metal ions, alloys and salts
US20080078408A1 (en) * 2005-04-18 2008-04-03 Park Benjamin W Urethral condoms and liquid female condoms
WO2008005705A2 (en) * 2006-06-30 2008-01-10 Nucryst Pharmaceuticals Corp. Metal-containing formulations and methods of use
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US20080175925A1 (en) * 2007-01-23 2008-07-24 Oxford J Craig Method and composition for the treatment of herpes virus
US8865227B2 (en) * 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
WO2012112940A1 (en) 2011-02-18 2012-08-23 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
EA201400826A1 (ru) * 2012-10-19 2014-11-28 Общество с ограниченной ответственностью "Нанобиотех" Стимулятор и способ стимуляции роста и развития растений
US10046079B2 (en) 2013-03-15 2018-08-14 Materials Modification Inc. Clay composites and their applications
FI128711B (en) * 2017-03-17 2020-10-30 Jyri Nieminen Procedure for the treatment of herpes simplex symptoms on the skin and mucous membranes of mammals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761590A (en) * 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns
US4415565A (en) * 1980-03-18 1983-11-15 The United States Of America As Represented By The Secretary Of The Army Silver metachloridine in treatment of infections
AU596272B2 (en) * 1987-02-25 1990-04-26 Trustees Of Columbia University In The City Of New York, The Method of inhibiting the transmission of aids virus

Also Published As

Publication number Publication date
EP0640345A2 (de) 1995-03-01
JPH04502148A (ja) 1992-04-16
AU4486489A (en) 1990-05-14
JP2799210B2 (ja) 1998-09-17
EP0439513A4 (en) 1992-01-02
US4952411A (en) 1990-08-28
WO1990004390A1 (en) 1990-05-03
AU622945B2 (en) 1992-04-30
EP0439513B1 (de) 1996-03-13
EP0439513A1 (de) 1991-08-07
DE68925975D1 (de) 1996-04-18
EP0640345A3 (de) 1995-03-29

Similar Documents

Publication Publication Date Title
DE68925975T2 (de) Zusammensetzung zur Verhinderung der übertragung von AIDS.
DE3884461D1 (de) Antibiotikum-polymer zusammensetzung.
NL193682B (nl) Beklede cefuroximaxetilsamenstelling.
DK594188D0 (da) Transmissionsmedium af komposittypen
DE3763334D1 (de) Kupplungsbestandteil.
NO902038D0 (no) Bitumenpolymerblandinger.
DE3870011D1 (de) Hartbutter-zusammensetzung.
DE3867594D1 (de) Zementzusammensetzung.
FI883238A0 (fi) Mikrobicid komposition.
NO880262D0 (no) Fremgangsmaate for fremstilling av b avermectiner.
FI881120A (fi) Foerfarande foer framstaellning av cement.
DE3878523T2 (de) Beschichtungszusammensetzung.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
NO885263D0 (no) Klebemiddelsammensetning.
DE3863957D1 (de) Zementzusammensetzungen.
DE3884910D1 (de) Polypropylen-Zusammensetzung.
DE3887904D1 (de) Nachräumer zur bohrlocherweiterung.
FI880158A0 (fi) Diuretisk komposition.
DE3869471D1 (de) Fiebersteigende zusammensetzung.
NO904285D0 (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
DE3874071D1 (de) Zahnsteinverhindernde zusammensetzung.
ES536843A0 (es) Procedimiento de preparacion de bencensulfonamidas y similares.
NO881274D0 (no) Maling- eller lakkblanding.
DE3880006D1 (de) Ueberzugszusammensetzung.
DE3868222D1 (de) Beschichtungszusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee